---
title: "Ligand CLO, Secretary Andrew Reardon disposes of common shares worth $1.53 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291845425.md"
description: "Ligand Pharmaceuticals CLO and Secretary Andrew Reardon sold 5,000 common shares worth approximately $1.53 million on July 1, 2026, under a Rule 10b5-1 plan. The sales occurred at weighted-average prices between $308.99 and $317.15. Concurrently, Reardon acquired 5,000 shares via option exercises at $52.27 to offset the sales, leaving him with 41,514 directly owned shares as of July 1."
datetime: "2026-07-06T21:12:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291845425.md)
  - [en](https://longbridge.com/en/news/291845425.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291845425.md)
generator: "portal-rs"
---

# Ligand CLO, Secretary Andrew Reardon disposes of common shares worth $1.53 million

-   Ligand Pharmaceuticals CLO and Secretary Andrew Reardon reported net sales of 5,000 common shares on July 1, 2026 under a Rule 10b5-1 plan. \* Sales were executed at weighted-average prices ranging from $308.99 to $317.15. \* He also acquired 5,000 shares through option exercise at $52.27, offsetting the sales. \* Reardon ended July 1 with 41,514 shares directly owned. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ligand Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002001011-26-000108), on July 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [LGND.US](https://longbridge.com/en/quote/LGND.US.md)

## Related News & Research

- [$100 Invested In Ligand Pharmaceuticals 10 Years Ago Would Be Worth This Much Today](https://longbridge.com/en/news/296632631.md)
- [Ranger Investment Management L.P. Acquires Shares of 257,596 Ligand Pharmaceuticals Incorporated $LGND](https://longbridge.com/en/news/296772770.md)
- [Fleury board holding increases by R$ 70,053.75 after on-market share buy](https://longbridge.com/en/news/296728002.md)
- [Fluidra buys back 259,500 shares Aug 18-21 at average price 19.15](https://longbridge.com/en/news/296870067.md)
- [KER Holding, linked to Clariane director HLD Europe, purchases EUR 0.27 million of Clariane shares](https://longbridge.com/en/news/296938133.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**